Drug
AGN-190584 clinical trials
Also written AGN-190584.
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2016 | 2 |
| 2021 | 1 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AGN-190584 is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of AgeCompletedPhase 3AbbVieNCT04837482Written as AGN-190584
- Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact LensesWithdrawnPhase 4Gordon Schanzlin New VisionNCT05624320Written as AGN-190584
- Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic PresbyopiaWithdrawnPhase 2AllerganNCT05393089Written as AGN-190584
- A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With PresbyopiaCompletedPhase 2AllerganNCT02780115Written as AGN-190584 ophthalmic solution
- A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With PresbyopiaCompletedPhase 2AllerganNCT02595528Written as AGN-190584 ophthalmic solution
- Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With PresbyopiaCompletedPhase 2AllerganNCT02197806Written as AGN-190584